SCHEMBL20245672

SCHEMBL20245672

CCN(C)CCON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23119189 0.84
SCHEMBL19703336 0.81
SCHEMBL15618888 0.77 CHRNB2 (0.39)
SCHEMBL96919 0.74
SCHEMBL1509476 0.74
SCHEMBL4901739 0.74
SCHEMBL2126204 0.73
SCHEMBL371246 0.72
Hydrochloric Acid SCHEMBL9616743 0.72 POLB (0.43)
Hydrochloric Acid SCHEMBL10556422 0.72 POLB (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020132483-A1 RIFAMYCIN ANALOGS AND ANTIBODY-DRUG CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2020-06-25 WO disclosed
EP-3333156-A2 BENZOMORPHAN ANALOGS AND THE USE THEREOF Purdue Pharma L.P. (US) 2018-06-13 EP disclosed